Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Massimi

Showing results (231-240 of 245) with videos related to

Pageof 25
Sort By:
Cancer Cell|August 16, 2011
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymomaHendrik Witt, Stephen C Mack, Marina Ryzhova, et al.
Cell|January 24, 2012
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutationsTobias Rausch, David T W Jones, Marc Zapatka, et al.
Acta Neuropathologica|August 19, 2021
Subgroup and subtype-specific outcomes in adult medulloblastomaHallie Coltin, Lakshmikirupa Sundaresan, Kyle S Smith, et al.
Cancer Cell|July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain TumorPatrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Cell Reports. Medicine|August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated MedulloblastomaLiana Nobre, Michal Zapotocky, Sara Khan, et al.
Neuro-Oncology|June 28, 2023
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndromeAnna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Pageof 25

Showing results (231-240 of 245) with videos related to

Sort By:
Pageof 25
Cancer Cell|August 16, 2011
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymomaHendrik Witt, Stephen C Mack, Marina Ryzhova, et al.
Cell|January 24, 2012
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutationsTobias Rausch, David T W Jones, Marc Zapatka, et al.
Acta Neuropathologica|August 19, 2021
Subgroup and subtype-specific outcomes in adult medulloblastomaHallie Coltin, Lakshmikirupa Sundaresan, Kyle S Smith, et al.
Cancer Cell|July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain TumorPatrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Cell Reports. Medicine|August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated MedulloblastomaLiana Nobre, Michal Zapotocky, Sara Khan, et al.
Neuro-Oncology|June 28, 2023
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndromeAnna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Pageof 25